Trials / Conditions / Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)
Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)
4 registered clinical trials studyying Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | A Study of NDV-01 as an Intravesical Administration to Patients With BCG-Unresponsive Non-Muscle Invasive Blad NCT07342517 | Relmada Therapeutics, Inc. | Phase 3 |
| Not Yet Recruiting | A Study of NDV-01 (Sustained-release Gemcitabine-docetaxel) in Participants With Non-muscle Invasive Bladder C NCT07464145 | Relmada Therapeutics, Inc. | Phase 3 |
| Withdrawn | A Study of Adjuvant NDV-01 (Sustained-release Gemcitabine-docetaxel) for the Treatment of Intermediate Risk NM NCT07313891 | Relmada Therapeutics, Inc. | Phase 3 |
| Completed | Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer NCT01108055 | Sandy Srinivas | Phase 2 |